+

Diaceutics Global Data Repository leads the way to smarter data-enabled precision medicine at ASCO 2020

Diaceutics Global Data Repository leads the way to smarter data-enabled precision medicine at ASCO 2020

Diaceutics will demonstrate the valuable role of real-world testing data in improving precision medicine at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place virtually from May 29-31. This year, Diaceutics, a precision diagnostics commercialization company for the global pharmaceutical industry, will present a poster and 4 abstracts. Each study features data analyzed from the Diaceutics proprietary Global Data Lake, which holds more than 227 million real-world patient records from 35 countries.

The poster and abstracts can be accessed here:

  • Poster #7528: Stability of rare TP53 co-mutations in AML patients. Kenneth J Bloom MD; Adam Idica PhD, Dave Smart PhD, Wendy L Allen PhD, Enya Scanlon MRes, Jordan Clark MPhil (Publication on May 29th, 2020)
  • Abstract # e18052: HRD in Ovarian Cancer – Defined Today, Evolving for the Future. Markus Eckstein MD, Kenneth J Bloom MD, Peter V Riccelli PhD, Frank Policht BA, Derry Mae Keeling BSc, Jordan Clark MPhil  https://meetinglibrary.asco.org/record/190929/abstract
  • Abstract # e13652: Economic burden of not testing for FLT3 to treat Acute Myeloid Leukemia. Raymond Henderson PhD, Dave Smart PhD, Declan French PhD, Jordan Clark MPhil, Kenneth Bloom MD, Derek Hosty BTech, Mark Lawler PhD, FRCPath https://meetinglibrary.asco.org/record/189394/abstract
  • Abstract #e15574: Use of real-world clinical lab data to reveal Asian NTRK fusion test availability patterns. Markus Eckstein MD, Kenneth J Bloom MD, Susanne Munksted MSc, Marieke Hoefsmit MSc, Jordan Clark MPhil  https://meetinglibrary.asco.org/record/188925/abstract
  • Abstract # e15667: Drugging the Undruggable: A Market Readiness Analysis for KRAS-G12C. Fotios Loupakis MD, PhD, Kenneth J. Bloom MD, Wendy L Allen PhD, Enya E Scanlon MRes, Isabel Stacey MMath, Derry Mae Keeling BSc, Nital Patel MBA, Jordan Clark MPhil  https://meetinglibrary.asco.org/record/188619/abstract

About Diaceutics
Diaceutics PLC is a leading diagnostic commercialization company for the global pharmaceutical industry. The Company, quoted on the Alternative Investment Market (AIM) of the London Stock Exchange, is enabling Pharma to accelerate their market penetration and achieve a better return on precision medicine therapies by helping them to revolutionise patient testing. By generating insights from its data lake of clinical laboratory testing data and other data, Diaceutics helps Pharma understand and leverage the diagnostic landscape through initiatives that improve patient testing, leading to better treatment outcomes. The Company works with more than 30 global pharmaceutical companies across hundreds of precision medicine projects. The Company employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries.  www.diaceutics.com

Latest Blogs

Latest Blogs